Significance of intraoperative peritoneal culture of fungus in perforated peptic ulcer

British Journal of Surgery

Volumn 90, Issue 10, 2003, Pages 1215-1219

  Shan, Y S ^a   Hsu, H P ^a   Hsieh, Y H ^a   Sy, E D ^a   Lee, J C ^a   Lin, P W ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT;

ADULT; AGING; ANTIBIOTIC THERAPY; ARTICLE; CANDIDA; CANDIDIASIS; CRITICAL ILLNESS; ELECTROLYTE DISTURBANCE; FEMALE; FUNGUS CULTURE; HUMAN; INTRAOPERATIVE PERIOD; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; MYCOSIS; NEPHROTOXICITY; PEPTIC ULCER; PERITONEAL FLUID; PERITONITIS; POSTOPERATIVE INFECTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; SURGICAL INFECTION; ULCER PERFORATION;

AGED; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; APACHE; ASCITIC FLUID; FEMALE; FUNGI; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOSES; PEPTIC ULCER PERFORATION; PERITONITIS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURGICAL WOUND INFECTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0142247151     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4267     Document Type: Article

References (25)

1. Wittmann DH, Schein M, Condon RE. Management of secondary peritonitis. Ann Surg 1996; 224: 10-18.
2. Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985; 7: 646-655.
3. Berrouane YF, Herwaldt LA, Pfaller MA. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J Clin Microbiol 1999; 37: 531-537.
4. Wallace WC, Cinat ME, Nastanski F, Gornick WB, Wilson SE. New epidemiology for postoperative nosocomial infections. Am Surg 2000; 66: 874-878.
5. Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract - the 'undrained abscess' of multiple organ failure. Ann Surg 1993; 218: 111-119.
6. Koness RJ, Cutitar M, Burchard KW. Perforated peptic ulcer. Determinants of morbidity and mortality. Am Surg 1990; 56: 280-284.
7. Rutledge R, Mandel SR, Wild RE. Candida species. Insignificant contaminant or pathogenic species. Am Surg 1986; 52: 299-302.
8. Calandra T, Bille J, Schneider R, Mosimann F, Francioli P. Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet 1989; ii: 1437-1440.
9. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Am J Infect Control 1999; 27: 97-134.
10. Billing A, Fröhlich D, Schildberg FW. Prediction of outcome using the Mannheim peritonitis index in 2003 patients. Peritonitis Study Group. Br J Surg 1994; 81: 209-213.
11. Schönebeck J. Incidence of yeast-like fungi in gastric juice under normal and pathologic conditions. Scand J Gastroenterol 1968; 3: 351-354.
12. Krause Q, Matheis H, Wulf K. Fungemia and funguria after oral administration of Candida albicans. Lancet 1969; i: 598-599.
13. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220: 751-758.
14. Eubanks PJ, de Virgilio C, Klein S, Bongard F. Candida sepsis in surgical patients. Am J Surg 1993; 166: 617-620.
15. Sandven P, Qvist H, Skovlund E, Giercksky KE. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med 2002; 30: 541-547.
16. Grunau G, Heemken R, Hau T. Predictors of outcome in patients with postoperative intra-abdominal infection. Eur J Surg 1996; 162: 619-625.
17. Bosscha K, Reijnders K, Hulstaert PF, Algra A, van der Werken C. Prognostic scoring systems to predict outcome in peritonitis and intra-abdominal sepsis. Br J Surg 1997; 84: 1532-1534.
18. Pacelli F, Doglietto GB, Alfieri S, Piccioni E, Sgadari A, Gui D et al. Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients. Arch Surg 1996; 131: 641-645.
19. Lee FYJ, Leung KL, Lai BSP, Ng SSM, Dexter S, Lau WY. Predicting mortality and morbidity of patients operated on for perforated peptic ulcers. Arch Surg 2001; 136: 90-94.
20. Sawyer RG, Adams RB, Rosenlof LK, May AK, Pruett TL. The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation. Am Surg 1995; 61: 726-731.
21. Sabra R, Branch RA. Amphotericin B nephrotoxicity. Drug Saf 1990; 5: 94-108.
22. Solomkin JS, Flohr AB, Quie PG, Simmons RL. The role of Candida in intraperitoneal infections. Surgery 1980; 88: 524-530.
23. Bayer AS, Blumenkrantz MJ, Montgomerie JZ, Galpin JE, Coburn JW, Guze LB. Candida peritonitis. Report of 22 cases and review of the English literature. Am J Med 1976; 61: 832-840.
24. Nolla-Salas S, León C, Torres-Rodríguez JM, Martín E, Sitges-Serra A. Treatment of candidemia in critically ill surgical patients with intravenous fluconazole. Clin Infect Dis 1992; 14: 952-954.
25. Voss A, de Pauw BE. High-dose fluconazole therapy in patients with severe fungal infections. Eur J Clin Microbiol Infect Dis 1999; 18: 165-174.